We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.06B
AUM Growth
+$11.1M
Cap. Flow
-$39M
Cap. Flow %
-3.69%
Top 10 Hldgs %
18.29%
Holding
2,111
New
638
Increased
394
Reduced
467
Closed
537

Sector Composition

Rank Sector Weight
1 Technology 18.22%
2 Healthcare 13.36%
3 Communication Services 10.32%
4 Consumer Discretionary 7.52%
5 Industrials 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBW icon
1501
Build-A-Bear
BBW
$425M
$2K ﹤0.01%
+220
New +$2.24K
SLAI
1502
DELISTED
SOLAI Ltd ADS
SLAI
$2K ﹤0.01%
+3
New +$2.31K
CPRX
1503
DELISTED
Catalyst Pharmaceutical
CPRX
$2K ﹤0.01%
+810
New +$1.69K
DAIO icon
1504
Data I/O
DAIO
$30.1M
$2K ﹤0.01%
+300
New +$2K
FSM icon
1505
Fortuna Silver Mines
FSM
$2.62B
$2K ﹤0.01%
+500
New +$2.4K
GERN icon
1506
Geron
GERN
$808M
$2K ﹤0.01%
+568
New +$1.51K
MATX icon
1507
Matsons
MATX
$6.31B
$2K ﹤0.01%
55
-92
-63% -$2.82K
NTAP icon
1508
NetApp
NTAP
$36.1B
$2K ﹤0.01%
+50
New +$1.99K
PLAB icon
1509
Photronics
PLAB
$1.85B
$2K ﹤0.01%
200
-300
-60% -$3.17K
PLUS icon
1510
ePlus
PLUS
$2.45B
$2K ﹤0.01%
+66
New +$2.39K
PLX icon
1511
Protalix BioTherapeutics
PLX
$189M
$2K ﹤0.01%
+200
New +$1.88K
PRQR icon
1512
ProQR Therapeutics
PRQR
$243M
$2K ﹤0.01%
+300
New +$1.49K
VMC icon
1513
Vulcan Materials
VMC
$36.6B
$2K ﹤0.01%
+14
New +$1.76K
XENE icon
1514
Xenon Pharmaceuticals
XENE
$6.02B
$2K ﹤0.01%
+738
New +$2.88K
JE
1515
DELISTED
Just Energy Group Inc
JE
$2K ﹤0.01%
9
-564
-98% -$106K
CSFL
1516
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$2K ﹤0.01%
+100
New +$2.49K
LBY
1517
DELISTED
Libbey, Inc.
LBY
$2K ﹤0.01%
+300
New +$2.92K
JCP
1518
DELISTED
J.C. Penney Company, Inc.
JCP
$2K ﹤0.01%
500
-3,300
-87% -$16.9K
FWP
1519
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$2K ﹤0.01%
+14
New +$1.95K
ECYT
1520
DELISTED
Endocyte, Inc. Common Stock
ECYT
$2K ﹤0.01%
1,300
-10,900
-89% -$23.4K
AVHI
1521
DELISTED
A V Homes, Inc.
AVHI
$2K ﹤0.01%
+100
New +$1.72K
PQ
1522
DELISTED
Petroquest Energy Inc Wd
PQ
$2K ﹤0.01%
1,000
PACD
1523
DELISTED
Pacific Drilling S A
PACD
$2K ﹤0.01%
+1,000
New +$1.83K
ABEV icon
1524
Ambev
ABEV
$47.3B
$1K ﹤0.01%
+200
New +$1.14K
ADBE icon
1525
Adobe
ADBE
$101B
$1K ﹤0.01%
+5
New +$685

Similar funds

Prelude Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Prelude Capital Management held 2,111 positions worth $1.06B, up 1.1% from $1.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Prelude Capital Management withdrew a net $39M in Q2 2017, closing 537 positions and reducing 467 holdings. Its most notable exit was The WhiteWave Foods Company, an estimated $13.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 11% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Prelude Capital Management opened a new position in Altaba Inc worth $16.4M.

  • Prelude Capital Management's largest Q2 2017 buy was Altaba Inc: 301,001 shares worth $16.4M.
  • Prelude Capital Management added most to CR Bard Inc. in Q2 2017, an estimated $24.5M increase.
  • Prelude Capital Management's biggest Q2 2017 reduction was T-Mobile US, cutting an estimated $9.34M.
  • Prelude Capital Management fully exited The WhiteWave Foods Company in Q2 2017, selling an estimated $13.3M.
  • Prelude Capital Management's ten largest holdings make up 18% of its $1.06B portfolio in Q2 2017.
  • Prelude Capital Management opened 638 new positions and closed 537 in Q2 2017.
  • Prelude Capital Management's portfolio value rose 1.1% quarter-over-quarter to $1.06B.

Based on Prelude Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.